Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The mechanisms underlying montelukast's neuropsychiatric effects - new insights from a combined metabolic and multiomics approach
Cátia F. Marques, M. Matilde Marques, Gonçalo C. Justino
Life Sciences (2022) Vol. 310, pp. 121056-121056
Open Access | Times Cited: 20

Showing 20 citing articles:

Montelukast Use and the Risk of Neuropsychiatric Adverse Events in Children
Viktor Wintzell, Philip Brenner, Linda Halldner, et al.
JAMA Pediatrics (2025)
Closed Access | Times Cited: 1
Neuropsychiatric events associated with montelukast in patients with asthma: a systematic review
Chris Wai Hang Lo, Swathi Pathadka, Simon Xiwen Qin, et al.
European Respiratory Review (2023) Vol. 32, Iss. 169, pp. 230079-230079
Open Access | Times Cited: 16
The Impact of Montelukast Duration on the Risk of Neuropsychiatric Disorders in Children with Asthma: A Population-Based Cohort Study
Wei‐Te Lei, Chien‐Yu Lin, Szu-Hung Chu, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 379-379
Open Access
Computational Investigation of Montelukast and Its Structural Derivatives for Binding Affinity to Dopaminergic and Serotonergic Receptors: Insights from a Comprehensive Molecular Simulation
Nasser Alotaiq, Doni Dermawan
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 559-559
Open Access
Montelukast Induces Depressive‐Like Behaviour in ICR Young Mice Through Oxidative Stress and Inflammatory Response
Shalawate Ayijiang, Murezati Tiliwaerde, Yaqi Yang, et al.
Basic & Clinical Pharmacology & Toxicology (2025) Vol. 136, Iss. 5
Closed Access
Pediatric suicide: Review of a preventable tragedy
Donald E. Greydanus, Ahsan Nazeer, Zheala Qayyum, et al.
Disease-a-Month (2024) Vol. 70, Iss. 9, pp. 101725-101725
Closed Access | Times Cited: 3
Neuromodulatory Effects of Leukotriene receptor antagonists: A comprehensive review
Radhika Sood, Shailendra Anoopkumar‐Dukie, Santosh Rudrawar, et al.
European Journal of Pharmacology (2024) Vol. 978, pp. 176755-176755
Open Access | Times Cited: 3
Risk of neuropsychiatric adverse events associated with montelukast use in children and adolescents: a population-based case-crossover study
Jae Won Kim, Myeong Seong Kim, Min Sook Seo, et al.
BMJ Paediatrics Open (2024) Vol. 8, Iss. 1, pp. e002483-e002483
Open Access | Times Cited: 2
An Optimised MS-Based Versatile Untargeted Metabolomics Protocol
Cátia F. Marques, Gonçalo C. Justino
Separations (2023) Vol. 10, Iss. 5, pp. 314-314
Open Access | Times Cited: 4
Suspected Adverse Drug Reactions Associated with Leukotriene Receptor Antagonists Versus First Line Asthma Medications: A National Registry-Pharmacology Approach
Mohammed Khan, Christine Hirsch, Alan M. Jones
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Cognitive, Emotional, and Behavioral Disorders in Children with Respiratory Allergic Diseases: Causes and Solutions
Natalia V. Ustinova, George A. Karkashadze, Leyla S. Namazova-Baranova
Педиатрическая фармакология (2024) Vol. 21, Iss. 3, pp. 226-239
Open Access | Times Cited: 1
Cysteinyl Leukotriene Receptor Antagonism by Montelukast to Treat Visual Deficits
Amritha T. M. Seetharaman, Caroline Owens, Rajashekhar Gangaraju
Journal of Ocular Pharmacology and Therapeutics (2024)
Closed Access | Times Cited: 1
Neuropsychiatric diagnoses after montelukast initiation in paediatric patients with asthma
Tapio Paljärvi, Julian Forton, Courtney Thompson, et al.
Thorax (2024), pp. thorax-221590
Closed Access | Times Cited: 1
Leukotriene receptor antagonists in the treatment of bronchial asthma: Consensus agreement “Bronchial Asthma and LEukoTriene receptor antagonists (BALET)”
С. Н. Авдеев, Н.А. Геппе, N I Ilina, et al.
Russian Journal of Allergy (2023) Vol. 20, Iss. 2, pp. 130-142
Open Access | Times Cited: 2
The effect of adding Montelukast to oxybutynin on daily urination in children with pollakiuria: a randomized clinical trial
Ali Arjmand Shabestari, H Aghaii Bakhtiari, Fatemeh Dorreh, et al.
International Urology and Nephrology (2023) Vol. 55, Iss. 9, pp. 2139-2144
Closed Access | Times Cited: 2
Side effects of drugs that act on the respiratory tract
Dinesh Yogaratnam, Katherine M. Carey, Valerie Coppenrath, et al.
Side effects of drugs annual (2023), pp. 147-160
Closed Access | Times Cited: 2
Protocol to study in vitro drug metabolism and identify montelukast metabolites from purified enzymes and primary cell cultures by mass spectrometry
Cátia F. Marques, Pedro F. Pinheiro, Gonçalo C. Justino
STAR Protocols (2023) Vol. 4, Iss. 1, pp. 102086-102086
Open Access | Times Cited: 1
Pediatric Asthma: Where Has Montelukast Gone?
Marco Maglione, Antonietta Giannattasio, Antonia Pascarella, et al.
Applied Sciences (2023) Vol. 13, Iss. 7, pp. 4146-4146
Open Access
The Association between Leukotriene-Modifying agents Use and Depression in Adults: A Population-based Analysis of the NHANES from 2007 to 2016
Jingchao Yan, Hong Sun, Xiu Xin, et al.
Authorea (Authorea) (2023)
Open Access
The elusive pathways behind montelukast's repurposing for Alzheimer's disease
Cátia F. Marques, M. Matilde Marques, Gonçalo C. Justino
Authorea (Authorea) (2022)
Open Access
Page 1

Scroll to top